Lotus Pharmaceuticals LTUS Stock
0.0055 USD
{{ price }}
14.791662%
{{change_pct}}%
SECTOR
Financial Services
INDUSTRY
Shell Companies
COUNTRY
United States
Exchange
OTC Markets OTCPK
Market Cap
14.85M USD
LOW - HIGH [24H]
0.0048
-
0.0054 USD
VOLUME [24H]
29.34K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.04 USD
Lotus Pharmaceuticals Price Chart
Lotus Pharmaceuticals LTUS Financial and Trading Overview
| Lotus Pharmaceuticals stock price | 0.0055 USD |
| Previous Close | 0.006 USD |
| Open | 0.006 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.006 - 0.006 USD |
| 52 Week Range | 0.005 - 0.02 USD |
| Volume | 14.47K USD |
| Avg. Volume | 6.59K USD |
| Market Cap | 834.49K USD |
| Beta (5Y Monthly) | 0.417605 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LTUS Valuation Measures
| Enterprise Value | 6.19M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.011689036 |
| Price/Book (mrq) | 0.0016773833 |
| Enterprise Value/Revenue | 0.087 |
| Enterprise Value/EBITDA | 0.601 |
Trading Information
Lotus Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.417605 |
| 52-Week Change | -33.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.005 USD |
| 50-Day Moving Average | 0.0092718 USD |
| 200-Day Moving Average | 0.01 USD |
LTUS Share Statistics
| Avg. Volume (3 month) | 6.59K USD |
| Avg. Daily Volume (10-Days) | 2.5K USD |
| Shares Outstanding | 27.82M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2010 |
| Most Recent Quarter (mrq) | September 30, 2011 |
| Next Fiscal Year End | December 31, 2011 |
Profitability
| Profit Margin | 2.43% |
| Operating Margin (ttm) | 11.43% |
| Gross Margin | 35.64% |
| EBITDA Margin | 14.43% |
Management Effectiveness
| Return on Assets (ttm) | 4.55% |
| Return on Equity (ttm) | 1.82% |
Income Statement
| Revenue (ttm) | 71.39M USD |
| Revenue Per Share (ttm) | 2.6 USD |
| Quarterly Revenue Growth (yoy) | 4.00% |
| Gross Profit (ttm) | 39.78M USD |
| EBITDA | 10.31M USD |
| Net Income Avi to Common (ttm) | 1.72M USD |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | -81.29% |
Balance Sheet
| Total Cash (mrq) | 158.91K USD |
| Total Cash Per Share (mrq) | 0.006 USD |
| Total Debt (mrq) | 6.18M USD |
| Total Debt/Equity (mrq) | 6.22 USD |
| Current Ratio (mrq) | 0.532 |
| Book Value Per Share (mrq) | 3.577 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 18.37M USD |
| Levered Free Cash Flow (ttm) | -5290145 USD |
Profile of Lotus Pharmaceuticals
| Country | United States |
| State | TN |
| City | Nashville |
| Address | 813 Blue Ridge Drive |
| ZIP | 37207 |
| Phone | 615 310 2688 |
| Website | https://lotuspharmaceuticalsusa.com |
| Industry | Shell Companies |
| Sector(s) | Financial Services |
| Full Time Employees | 233 |
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.
Q&A For Lotus Pharmaceuticals Stock
What is a current LTUS stock price?
Lotus Pharmaceuticals LTUS stock price today per share is 0.0055 USD.
How to purchase Lotus Pharmaceuticals stock?
You can buy LTUS shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lotus Pharmaceuticals?
The stock symbol or ticker of Lotus Pharmaceuticals is LTUS.
Which industry does the Lotus Pharmaceuticals company belong to?
The Lotus Pharmaceuticals industry is Shell Companies.
How many shares does Lotus Pharmaceuticals have in circulation?
The max supply of Lotus Pharmaceuticals shares is 2.7B.
What is Lotus Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Lotus Pharmaceuticals PE Ratio is now.
What was Lotus Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Lotus Pharmaceuticals EPS is -0.04 USD over the trailing 12 months.
Which sector does the Lotus Pharmaceuticals company belong to?
The Lotus Pharmaceuticals sector is Financial Services.